 a number of
guidelines on cardiovascular risk prevention in people
with diabetes and cardiovascular disease, and thus
another guideline would have little added value. It was
decided to base the Best Practice Statements on the
GVG for CLTI produced by the ESVS, SVS, and World
Federation of Vascular Societies (WFVS),20 as these
address the speciÔ¨Åc population of people with CLTI.
However, it was also felt that some of the